NCT03561961View on ClinicalTrials.gov

Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)

NAActive, not recruitingINTERVENTIONAL
Enrollment

526

Participants

Timeline

Start Date

May 24, 2018

Primary Completion Date

September 27, 2024

Study Completion Date

March 31, 2035

Conditions
Prostate Adenocarcinoma
Interventions
RADIATION

Moderate Hypo-fractionation

66-68Gy in 25#

RADIATION

Extreme Hypo-fractionation

35-36.25 Gy in 5#

Trial Locations (1)

410210

Dr Vedang Murthy, Navi Mumbai

All Listed Sponsors
collaborator

Tata Medical Center

OTHER

lead

Tata Memorial Centre

OTHER

NCT03561961 - Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial) | Biotech Hunter | Biotech Hunter